EMJ Hematology 11 [Supplement 1] . 2023

In this issue

This article reviews presentations that took place at the 64th American Society of Hematology (ASH) Annual Meeting, between 10th–13th December 2022, in New Orleans, Louisiana, USA. Exploring gene therapy for the treatment of haemophilia A and B by highlighting key updates from clinical trials and pre-clinical data, this congress review discusses recombinant adeno-associated virus (rAAV)-based gene therapy products and non-viral gene therapy strategies in haemophilia treatment, and details the translation from research into clinical practice.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?